CTOs on the Move

Alkeus Pharmaceuticals, Inc.

www.alkeuspharma.com

 
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Connecting Point Communications

Connecting Point Communications is a San Francisco, CA-based company in the Business Services sector.

Rounder Records Corporation

Rounder Records Corporation is one of the leading companies in the Business Services sector.

Best Event Products

Best Event Products is a Carlstadt, NJ-based company in the Business Services sector.

H-J Consultants

H-J Consultants is a Morristown, NJ-based company in the Business Services sector.

RealmOne

RealmOne provides advanced technology services and solutions focused on cybersecurity, intelligence collection and analysis, data science and advanced analytics, and hyper-automation to support our countrys most critical national security initiatives.